SEARCH RESULTS FOR: "Tag: REGN"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2022(1)
2021(5)
2020(8)
2019(3)
2018(5)
2017(17)
2016(12)
2015(7)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Update(4)
Analyst Upgrades(2)
Best and Worst Stocks(6)
Buzz Stocks(15)
By the Numbers(3)
Earnings Preview(2)
Editor's Pick(3)
Expectational Analysis(2)
General(2)
Indexes and ETFs(2)
Intraday Option Activity(5)
Market Recap(1)
Midday Market Check(4)
Opening View(5)
Quantitative Analysis(4)
Stock Market News(3)
Stocks On the Move(10)
Technical Analysis(2)
Unusual Trading Activity(1)

2/4/2022 10:26 AM
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is up 1.9% to trade at $632.42 at last check, after the drug maker posted a top- and bottom-line beat for its fourth quarter, which included revenues nearly...
12/1/2021 11:28 AM
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has been in the spotlight this week, after the company's CEO Leonard Schleifer noted its Covid-19 antibody cocktail may be less effective against the omicro...
11/4/2021 10:33 AM
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) threw its hat into the earnings ring this morning, reporting third-quarter earnings and revenue that trounced Wall Street's estimates. The company also po...
6/28/2021 10:43 AM
The shares of biotechnology name Intellia Therapeutics Inc (NASDAQ:NTLA) are soaring this morning, up 48% to trade at $131.92 at last check -- earlier hitting a record high of $144.39 -- after posit...
5/6/2021 10:40 AM
The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are rising on the company's upbeat first-quarter earnings report, which boasted a rise in profits to $9.89 per share -- toppling analysts' es...